-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $20

Benzinga·03/04/2026 20:36:54
Listen to the news
Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $17 to $20.